Literature DB >> 25791790

Increased Expression of Circulating Cancer Stem Cell Markers During the Perioperative Period Predicts Early Recurrence After Curative Resection of Hepatocellular Carcinoma.

Gi Hong Choi1,2, Gwang Il Kim3, Jeong Eun Yoo3, Deuk Chae Na3, Dai Hoon Han1,2, Yun Ho Roh4, Young Nyun Park5,6,7, Jin Sub Choi8,9.   

Abstract

BACKGROUND: This study was designed to investigate the correlation between postoperative recurrence of hepatocellular carcinoma (HCC) and perioperative expression and dynamic changes in cancer stem cell (CSC) markers in tumors and peripheral blood.
METHODS: In HCC patients who underwent curative resection (n = 64) or liver transplantation (LT) (n = 17), mRNA levels for K19, EpCAM, and CD44 in peripheral blood and HCC tissues before and after operation were examined using real-time RT-PCR. Postoperative recurrence was analyzed in patients who underwent resection. Study participants were divided into high and low ratio groups, according to the ratio of postoperative to preoperative mRNA levels for each marker.
RESULTS: K19 and CD44 mRNA levels in HCC tissues were higher in patients with recurrence than those without recurrence (p < 0.05 for all). Preoperative peripheral levels of K19 and EpCAM mRNA were higher in LT patients than in resection patients, and they were also significantly higher in cirrhotic patients of Child-Pugh Class B or C than those of Child-Pugh Class A (p < 0.05 for all). A high ratio of K19 mRNA was associated with lower relapse-free rate. Additionally, a high ratio for both K19 and CD44 mRNA was an independent poor prognostic factor for relapse-free survival (hazard ratio = 3.382, p = 0.016).
CONCLUSIONS: Preoperative peripheral levels of K19 and EpCAM mRNA were influenced by background liver status and HCC. Additionally, the ratio of postoperative to preoperative mRNA levels for CSC markers, especially K19 and CD44, was shown to be important to predict HCC recurrence.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25791790     DOI: 10.1245/s10434-015-4480-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  17 in total

1.  Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting.

Authors:  Yangyang Hu; Lin Lu; Yang Xia; Xin Chen; Alfred E Chang; Robert E Hollingsworth; Elaine Hurt; John Owen; Jeffrey S Moyer; Mark E P Prince; Fu Dai; Yangyi Bao; Yi Wang; Joel Whitfield; Jian-Chuan Xia; Shiang Huang; Max S Wicha; Qiao Li
Journal:  Cancer Res       Date:  2016-06-20       Impact factor: 12.701

Review 2.  Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression.

Authors:  Hyungjin Rhee; Haeryoung Kim; Young Nyun Park
Journal:  Liver Cancer       Date:  2020-10-23       Impact factor: 11.740

3.  CD44 Predicts Early Recurrence in Pancreatic Cancer Patients Undergoing Radical Surgery.

Authors:  Chih-Po Hsu; Li-Yu Lee; Jun-Te Hsu; Yu-Pao Hsu; Yu-Tung Wu; Shang-Yu Wang; Chun-Nan Yeh; Tse-Ching Chen; Tsann-Long Hwang
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

Review 4.  Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers.

Authors:  Chang-Qing Yin; Chun-Hui Yuan; Zhen Qu; Qing Guan; Hao Chen; Fu-Bing Wang
Journal:  Dis Markers       Date:  2016-06-15       Impact factor: 3.434

5.  MicroRNA-452 promotes stem-like cells of hepatocellular carcinoma by inhibiting Sox7 involving Wnt/β-catenin signaling pathway.

Authors:  Zhiyun Zheng; Jimin Liu; Zhe Yang; Limin Wu; Haiyang Xie; Chaozhe Jiang; Binyi Lin; Tianchi Chen; Chunyang Xing; Zhikun Liu; Penghong Song; Shengyong Yin; Shusen Zheng; Lin Zhou
Journal:  Oncotarget       Date:  2016-05-10

Review 6.  Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancer.

Authors:  Margherita Correnti; Chiara Raggi
Journal:  Oncotarget       Date:  2017-01-24

7.  Synergy of Dendritic Cell Vaccines and Avasimibe in Treatment of Head and Neck Cancer in Mice.

Authors:  Xin Chen; Qibin Song; Leiming Xia; Ximing Xu
Journal:  Med Sci Monit       Date:  2017-09-17

8.  ILs-3, 6 and 11 increase, but ILs-10 and 24 decrease stemness of human prostate cancer cells in vitro.

Authors:  Dandan Yu; Yali Zhong; Xiaoran Li; Yaqing Li; Xiaoli Li; Jing Cao; Huijie Fan; Yuan Yuan; Zhenyu Ji; Baoping Qiao; Jian-Guo Wen; Mingzhi Zhang; Gunnar Kvalheim; Jahn M Nesland; Zhenhe Suo
Journal:  Oncotarget       Date:  2015-12-15

Review 9.  Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.

Authors:  Wataru Okajima; Shuhei Komatsu; Daisuke Ichikawa; Mahito Miyamae; Takuma Ohashi; Taisuke Imamura; Jun Kiuchi; Keiji Nishibeppu; Tomohiro Arita; Hirotaka Konishi; Atsushi Shiozaki; Ryo Morimura; Hisashi Ikoma; Kazuma Okamoto; Eigo Otsuji
Journal:  World J Gastroenterol       Date:  2017-08-21       Impact factor: 5.742

Review 10.  Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.

Authors:  Lia Walcher; Ann-Kathrin Kistenmacher; Huizhen Suo; Reni Kitte; Sarah Dluczek; Alexander Strauß; André-René Blaudszun; Tetyana Yevsa; Stephan Fricke; Uta Kossatz-Boehlert
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.